What are Merck's main therapeutic areas of focus?

Merck & Co. is dedicated to addressing a variety of therapeutic areas with the intention of improving patient outcomes and advancing medical science. The company places a strong emphasis on infectious diseases, particularly vaccines and treatments for conditions such as HIV, hepatitis, and more recently, COVID-19. Additionally, Merck focuses on oncology, which encompasses the development of innovative therapies for various types of cancer, utilizing both traditional and novel approaches, including immunotherapy. Another significant area of focus is cardiometabolic disease, where Merck is engaged in creating solutions for conditions like diabetes and cardiovascular diseases. The company also invests resources in research related to women's health, with products aimed at addressing challenges unique to women at different life stages. Furthermore, Merck is involved in areas such as respiratory diseases, neuroscience, and even animal health. This broad portfolio highlights Merck's commitment to research and development that aligns with its mission to deliver solutions that enhance the quality of life. For the latest and most specific information about Merck's therapeutic areas and initiatives, individuals may find the Merck website a helpful resource.